These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29141049)

  • 21. Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer.
    Li C; Wang X; Casal I; Wang J; Li P; Zhang W; Xu E; Lai M; Zhang H
    J Cell Mol Med; 2016 Aug; 20(8):1420-6. PubMed ID: 26990020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A nomogram based on pretreatment levels of serum bilirubin and total bile acid levels predicts survival in colorectal cancer patients.
    Cao Y; Deng S; Yan L; Gu J; Yang J; Yang M; Liu L; Cai K
    BMC Cancer; 2021 Jan; 21(1):85. PubMed ID: 33478423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of pretreatment plasma fibrinogen level in patients with digestive system tumors: a meta-analysis.
    Ji R; Ren Q; Bai S; Wang Y; Zhou Y
    Int J Biol Markers; 2018 Aug; 33(3):254-265. PubMed ID: 29874984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis.
    Jiang Y; Li W; He X; Zhang H; Jiang F; Chen Z
    BMC Cancer; 2015 Dec; 15():948. PubMed ID: 26674601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis.
    Jiang Y; Li W; He X; Zhang H; Jiang F; Chen Z
    BMC Cancer; 2016 Jan; 16():12. PubMed ID: 26758198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Elevated Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Colorectal Cancer: A Meta-Analysis.
    Huang XZ; Chen WJ; Zhang X; Wu CC; Zhang CY; Sun SS; Wu J
    Dis Markers; 2017; 2017():1053125. PubMed ID: 28539688
    [No Abstract]   [Full Text] [Related]  

  • 27. Prognostic value of LGR5 in colorectal cancer: a meta-analysis.
    Chen Q; Zhang X; Li WM; Ji YQ; Cao HZ; Zheng P
    PLoS One; 2014; 9(9):e107013. PubMed ID: 25192390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term prognostic value of preoperative anemia in patients with colorectal cancer: A systematic review and meta-analysis.
    Wilson MJ; van Haaren M; Harlaar JJ; Park HC; Bonjer HJ; Jeekel J; Zwaginga JJ; Schipperus M
    Surg Oncol; 2017 Mar; 26(1):96-104. PubMed ID: 28317592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder.
    Ahmadi H; Djaladat H; Cai J; Miranda G; Daneshmand S
    Urol Oncol; 2014 Jul; 32(5):648-56. PubMed ID: 24680660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Value of Elevated Pre-treatment Serum CA-125 in Epithelial Ovarian Cancer: A Meta-Analysis.
    Wang Q; Feng X; Liu X; Zhu S
    Front Oncol; 2022; 12():868061. PubMed ID: 35463345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-Analysis.
    Song YX; Huang XZ; Gao P; Sun JX; Chen XW; Yang YC; Zhang C; Liu HP; Wang HC; Wang ZN
    Dis Markers; 2015; 2015():549843. PubMed ID: 26576068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Association of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Thymidine Kinase, and Tissue Polypeptide Specific Antigen with Outcomes of Patients with Metastatic Colorectal Cancer Treated with Bevacizumab: a Retrospective Study.
    Fiala O; Finek J; Buchler T; Matejka VM; Holubec L; Kulhankova J; Bortlicek Z; Liska V; Topolcan O
    Target Oncol; 2015 Dec; 10(4):549-55. PubMed ID: 25875421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poor Prognosis Significance of Pretreatment Thrombocytosis in Patients with Colorectal Cancer: a Meta-Analysis.
    Zhao JM; Wang YH; Yao N; Wei KK; Jiang L; Hanif S; Wang ZX
    Asian Pac J Cancer Prev; 2016; 17(9):4295-4300. PubMed ID: 27797233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of pretreatment plasma fibrinogen in patients with colorectal cancer: A systematic review and meta-analysis.
    Li M; Wu Y; Zhang J; Huang L; Wu X; Yuan Y
    Medicine (Baltimore); 2019 Sep; 98(37):e16974. PubMed ID: 31517816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.
    Li Y; Liu X; Zhang J; Yao W
    Cancer Biomark; 2016; 16(3):333-42. PubMed ID: 26835589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Value of NRAS Gene for Survival of Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
    Hu Y; Tao SY; Deng JM; Hou ZK; Liang JQ; Huang QG; Li LH; Li HB; Chen YM; Yi H; Chen XL; Liu H
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3001-3008. PubMed ID: 30484984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
    Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
    Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy-induced neutropenia and the prognosis of colorectal cancer: a meta-analysis of cohort studies.
    Tan X; Wen Q; Wang R; Chen Z
    Expert Rev Anticancer Ther; 2017 Nov; 17(11):1077-1085. PubMed ID: 28910204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients.
    Fahmueller YN; Nagel D; Hoffmann RT; Tatsch K; Jakobs T; Stieber P; Holdenrieder S
    Int J Cancer; 2013 May; 132(10):2349-58. PubMed ID: 23047645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.